CSIMarket
 


Avid Bioservices Inc   (CDMO)
Other Ticker:  
 


Avid Bioservices Inc 's Effective Tax Rate by quarter

Trends, Rankings, Statistics



CDMO Effective Tax Rate (Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
(Jan 31 2023)
III. Quarter
(Oct 31 2022)
II. Quarter
Y / Y Pre-Tax Income Change - - -23.68 % 12.54 % -
Seq. Pre-Tax Income Change - - -82.29 % - -
Pre-Tax Income In Millions $-11.89 $-2.68 $0.45 $2.53 $-3.24
Effective Tax Rate - - - 81.78 % -
Effective Tax Rate Total Ranking # # # 2176 # 2269 #
Income taxes expenses / -benefit In Millions $-2.38 $-0.59 $0.76 $2.07 $-2.09
Y / Y Income taxes expenses / -benefit Change - - - - -
Seq. Income taxes expenses / -benefit Change - - - - -


Commenting Second Quarter 2023 Effective Tax Rate
Avid Bioservices Inc recieved tax benefit in II. Quarter .

Looking into II. Quarter results within Major Pharmaceutical Preparations industry Avid Bioservices Inc achieved lowest Effective Tax Rate. While total ranking remained unchanged compare to previous quarter at no. .

CDMO's Effective Tax Rate second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

CDMO's Effective Tax Rate Statistics
High Average Low
168.97 % 93.92 % 31.01 %
(Apr 30 2023)   (Jul 31 2022)




Other Effective Tax Rate Profitability Ratios
CDMO's Cumulative Effective Tax Rate
Major Pharmaceutical Preparations Industry Effective Tax Rate Trends and Statistics
Healthcare Sector Effective Tax Rate Statistics
Effective Tax Rate Profitability Trends for overall market
CDMO's Effective Tax Rate Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Effective Tax Rate
Lowest Ranking Effective Tax Rate
Effective Tax Rate Profit Margin for CDMO's Competitors
Effective Tax Rate Profit Margin for Avid Bioservices Inc 's Suppliers
Effective Tax Rate Profit Margin for CDMO's Customers

You may also want to know
CDMO's Annual Growth Rates CDMO's Profitability Ratios CDMO's Asset Turnover Ratio CDMO's Dividend Growth
CDMO's Roe CDMO's Valuation Ratios CDMO's Financial Strength Ratios CDMO's Income taxes expenses / -benefit Growth
CDMO's Roa CDMO's Inventory Turnover Ratio CDMO's Growth Rates CDMO's Dividend Comparisons


Companies with similar Effective Tax Rate in the quarter ending Oct 31 2023, within Major Pharmaceutical Preparations Industry Effective Tax RateOct 31 2023 MRQ Income taxes expenses / -benefitOct 31 2023 MRQ Pre-Tax Income
Xeris Biopharma Holdings Inc   50.00 %$ 0.338 $ 0.676 
Cytomx Therapeutics Inc   48.55 %$ 2.823 $ 5.815 
Emmaus Life Sciences Inc   36.19 %$ 0.038 $ 0.105 
Nature s Sunshine Products inc   35.94 %$ 1.763 $ 4.905 
Pacira Biosciences inc   34.59 %$ 5.743 $ 16.601 
Collegium Pharmaceutical Inc   28.31 %$ 8.149 $ 28.783 
Organon and Co   27.50 %$ 22.000 $ 80.000 
Harmony Biosciences Holdings inc   25.80 %$ 13.371 $ 51.832 
Entrada Therapeutics Inc   24.53 %$ 17.398 $ 70.922 
Lifevantage Corp  24.13 %$ 0.200 $ 0.829 
United Therapeutics Corporation  23.93 %$ 84.200 $ 351.800 
Amphastar Pharmaceuticals Inc   22.04 %$ 14.025 $ 63.637 
Perrigo Company Plc  19.79 %$ 3.800 $ 19.200 
Viatris Inc   17.55 %$ 70.600 $ 402.200 
Johnson and Johnson  17.40 %$ 908.000 $ 5,217.000 
Zoetis Inc   16.88 %$ 121.000 $ 717.000 
Merck and Co Inc   15.48 %$ 870.000 $ 5,620.000 
Abbott Laboratories  14.06 %$ 235.000 $ 1,671.000 
Corcept Therapeutics Inc  13.76 %$ 5.007 $ 36.385 
Ani Pharmaceuticals Inc  13.65 %$ 1.571 $ 11.511 
Vertex Pharmaceuticals Inc  12.20 %$ 143.900 $ 1,179.200 
Prestige Consumer Healthcare Inc   11.97 %$ 16.856 $ 140.830 
Bristol myers Squibb Company  9.50 %$ 203.000 $ 2,137.000 
Regeneron Pharmaceuticals Inc   9.27 %$ 103.000 $ 1,110.800 
Abbvie inc   8.81 %$ 172.000 $ 1,953.000 
Amylyx Pharmaceuticals Inc   6.77 %$ 1.518 $ 22.411 
Beigene ltd   6.07 %$ 13.925 $ 229.338 
Innoviva Inc   4.54 %$ 3.906 $ 85.952 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com